Levodopa after 60 years: still a gold standard drug, with so many formulations to use.

What is it about?

After 60 years from its discovery, levodopa still represents the gold standard treatment for Parkinson's Disease. In this article we summarize evolution in pharmacokinetic and pharmacodynamic of levodopa, highlighting new formulations tested in trials and on the verge of coming to the market

Featured Image

Why is it important?

Not all levodopa formulations are the same. Rapid acting, long acting, extended release, "micro"pills, all have specific properties, and might be useful for specific conditions.